Zura Bio (ZURA) Share-based Compensation (2022 - 2026)

Zura Bio's Share-based Compensation history runs 5 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 37.43% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $24.7 million, a 230.64% increase from a year earlier, with the FY2025 full-year figure at $13.7 million, up 119.9% from the prior year.
• Share-based Compensation slipped to $5.0 million in Q1 2026 per ZURA's latest filing, from $12.3 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $15.8 million in Q3 2025 and bottomed at -$7.8 million in Q4 2024.
• The 5-year median for Share-based Compensation is $2.5 million (2022), against an average of $3.5 million.
• Across the five-year window, Share-based Compensation jumped 21375.0% in 2023 and plunged 423.77% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $13000.0 in 2022, then jumped by 18315.38% to $2.4 million in 2023, then plunged by 423.77% to -$7.8 million in 2024, then soared by 258.66% to $12.3 million in 2025, then slumped by 59.28% to $5.0 million in 2026.
• Per Business Quant, the three latest ZURA Share-based Compensation figures stand at $5.0 million (Q1 2026), $12.3 million (Q4 2025), and $15.8 million (Q3 2025).